GoodRx Reports Third Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
GoodRx Holdings, Inc. (GDRX) Misses Q3 EPS by 14c; Guides Lower
November 8, 2022 4:20 PM ESTGoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q3 EPS of ($0.10), $0.14 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $187.3 million versus the consensus estimate of $185.01 million.
GUIDANCE:
GoodRx Holdings, Inc. sees Q4 2022 revenue of $173-180 million, versus the... More
